Akoustis Technologies Inc (AKTS)

$0.04 0.00 (-9.05%)
Market Cap 5.75M
Revenue (ttm) 27.38M
Net Income (ttm) -167.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -613.40%
Debt to Equity Ratio 0.00
Volume 118,703,398
Avg Vol 26,170,799
Day's Range N/A - N/A
Shares Out 154.59M
Stochastic %K 6%
Beta 1.91
Analysts Sell
Price Target $1.00

Company Profile

Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., designs, develops, manufactures, and sells radio frequency (RF) filter products for the wireless industry in the Americas, Asia, Europe, and internationally. It operates in two segments, Fabrication Services and RF Filters. The Fabrication Services segment provides engineering review and backend packaging services. The RF Filters segment sells amplifier and filter products. It offers RF filters for the wireless industry, such a...

Industry: Communication Equipment
Sector: Technology
Phone: 704 997 5735
Fax: 704 997 5734
Address:
9805 Northcross Center Court, Suite A, Huntersville, United States
Alkafagy
Alkafagy Jan. 7 at 5:02 AM
$AKTS why price not moving on robinhood ?
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 7 at 1:28 AM
$SLS Jazz bought Celator for $1.5 billion for a close to approved aml drug. So whoever wrote $25 billion is way off. Keep an eye on $RADX ($60 million market cap) a peer is going public for 14x their market cap on Friday $AKTS (Aktis Oncology $840 million valuation) RADX is owned 14.5% by Lantheus and stock was just at $19 at pre market two weeks ago. Back down to $4.80 after they met they reported 92% for rad101 a brain imaging cancer Mets Theranostics and they claim would be 3rd largest imaging agent in world behind Lantheus and Telix’s. Those are $2-4 billion dollar enterprises. And I think RADX has a shot at being better
3 · Reply
RadioIsotope25
RadioIsotope25 Jan. 6 at 2:42 PM
$RADX When $AKTS goes public on Friday and has a market cap of a billion Radiopharm Theranostics going to look like a complete gem considering 14.5% owned by radiopharmaceutical giant and md anderson creating assets for them plus RADX is ahead of them on b7-h3 $60 million maket cap RADX $860 million AKTS on Friday
0 · Reply
smartkarma
smartkarma Jan. 6 at 10:06 AM
$AKTS | Aktis Oncology Launches the 2026 IPO Calendar With Nasdaq Offering "Aktis Oncology, Inc . is set to become the first IPO of 2026 , formally opening the new issuance calendar with a Nasdaq Global Market debut under..." - IPO Prophet (IPO Prophet) Read more: https://www.smartkarma.com/insights/aktis-oncology-launches-the-2026-ipo-calendar-with-nasdaq-offering
0 · Reply
smartkarma
smartkarma Jan. 6 at 8:05 AM
$AKTS | Aktis Oncology, Inc. (AKTS): Radiopharmaceutical Sets Terms for IPO Seeking $840M Valuation "​Aktis Oncology set to debut on Nasdaq with 11.8 million shares at $16–$18, backed by strong investor interest in their innovative radiopharmaceutical platform." - IPO Boutique (IPO Boutique) Read more: https://www.smartkarma.com/insights/aktis-oncology-inc-akts-radiopharmaceutical-sets-terms-for-ipo-seeking-840m-valuation
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 6 at 3:56 AM
$AKTS
0 · Reply
IPOtweet
IPOtweet Jan. 5 at 3:32 PM
US IPO Week Ahead: Aktis Oncology set to open 2026 IPO Market $EQPT $MTVE $AKTS $APC $MMED $IPO #IPO https://zpr.io/vfZStsTWQmh9
0 · Reply
smartkarma
smartkarma Jan. 5 at 2:11 PM
$AKTS | Aktis Oncology, Inc. (AKTS): Peeking at the IPO Prospectus of a Radiopharmaceutical Company "​Biotech company Aktis Oncology is leading the way in the 2026 IPO market with plans to debut on January 9, aiming to raise up to $200 million for their innovative cancer treatment research." - IPO Boutique (IPO Boutique) Read more: https://www.smartkarma.com/insights/aktis-oncology-inc-akts-peeking-at-the-ipo-prospectus-of-a-radiopharmaceutical-company
0 · Reply
IPOtweet
IPOtweet Jan. 2 at 10:27 PM
US IPO Week Ahead: 2026 set to start on a quiet note $EQPT $MTVE $AKTS $APC $MMED $IPO #IPO https://zpr.io/qdappu4XaYSC
0 · Reply
Abdi4136
Abdi4136 Dec. 25 at 7:55 PM
$ZPTA $MOND da bunun gibi olabilir mi yada $AKTS yada $SLNA hisseler hakında bilgisi olanlar
0 · Reply
Latest News on AKTS
Aktis Oncology files for US IPO as biotech listings rebound

Dec 19, 2025, 5:51 PM EST - 18 days ago

Aktis Oncology files for US IPO as biotech listings rebound

Phase 1 solid tumor biotech Aktis Oncology files for a $100 million IPO

Dec 19, 2025, 5:51 PM EST - 18 days ago

Phase 1 solid tumor biotech Aktis Oncology files for a $100 million IPO

Aktis Oncology IPO Registration Document (S-1)

Dec 19, 2025, 4:02 PM EST - 18 days ago

Aktis Oncology IPO Registration Document (S-1)

Alkafagy
Alkafagy Jan. 7 at 5:02 AM
$AKTS why price not moving on robinhood ?
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 7 at 1:28 AM
$SLS Jazz bought Celator for $1.5 billion for a close to approved aml drug. So whoever wrote $25 billion is way off. Keep an eye on $RADX ($60 million market cap) a peer is going public for 14x their market cap on Friday $AKTS (Aktis Oncology $840 million valuation) RADX is owned 14.5% by Lantheus and stock was just at $19 at pre market two weeks ago. Back down to $4.80 after they met they reported 92% for rad101 a brain imaging cancer Mets Theranostics and they claim would be 3rd largest imaging agent in world behind Lantheus and Telix’s. Those are $2-4 billion dollar enterprises. And I think RADX has a shot at being better
3 · Reply
RadioIsotope25
RadioIsotope25 Jan. 6 at 2:42 PM
$RADX When $AKTS goes public on Friday and has a market cap of a billion Radiopharm Theranostics going to look like a complete gem considering 14.5% owned by radiopharmaceutical giant and md anderson creating assets for them plus RADX is ahead of them on b7-h3 $60 million maket cap RADX $860 million AKTS on Friday
0 · Reply
smartkarma
smartkarma Jan. 6 at 10:06 AM
$AKTS | Aktis Oncology Launches the 2026 IPO Calendar With Nasdaq Offering "Aktis Oncology, Inc . is set to become the first IPO of 2026 , formally opening the new issuance calendar with a Nasdaq Global Market debut under..." - IPO Prophet (IPO Prophet) Read more: https://www.smartkarma.com/insights/aktis-oncology-launches-the-2026-ipo-calendar-with-nasdaq-offering
0 · Reply
smartkarma
smartkarma Jan. 6 at 8:05 AM
$AKTS | Aktis Oncology, Inc. (AKTS): Radiopharmaceutical Sets Terms for IPO Seeking $840M Valuation "​Aktis Oncology set to debut on Nasdaq with 11.8 million shares at $16–$18, backed by strong investor interest in their innovative radiopharmaceutical platform." - IPO Boutique (IPO Boutique) Read more: https://www.smartkarma.com/insights/aktis-oncology-inc-akts-radiopharmaceutical-sets-terms-for-ipo-seeking-840m-valuation
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 6 at 3:56 AM
$AKTS
0 · Reply
IPOtweet
IPOtweet Jan. 5 at 3:32 PM
US IPO Week Ahead: Aktis Oncology set to open 2026 IPO Market $EQPT $MTVE $AKTS $APC $MMED $IPO #IPO https://zpr.io/vfZStsTWQmh9
0 · Reply
smartkarma
smartkarma Jan. 5 at 2:11 PM
$AKTS | Aktis Oncology, Inc. (AKTS): Peeking at the IPO Prospectus of a Radiopharmaceutical Company "​Biotech company Aktis Oncology is leading the way in the 2026 IPO market with plans to debut on January 9, aiming to raise up to $200 million for their innovative cancer treatment research." - IPO Boutique (IPO Boutique) Read more: https://www.smartkarma.com/insights/aktis-oncology-inc-akts-peeking-at-the-ipo-prospectus-of-a-radiopharmaceutical-company
0 · Reply
IPOtweet
IPOtweet Jan. 2 at 10:27 PM
US IPO Week Ahead: 2026 set to start on a quiet note $EQPT $MTVE $AKTS $APC $MMED $IPO #IPO https://zpr.io/qdappu4XaYSC
0 · Reply
Abdi4136
Abdi4136 Dec. 25 at 7:55 PM
$ZPTA $MOND da bunun gibi olabilir mi yada $AKTS yada $SLNA hisseler hakında bilgisi olanlar
0 · Reply
IPOtweet
IPOtweet Dec. 19 at 10:33 PM
Phase 1 solid tumor biotech Aktis Oncology files for a $100 million IPO $AKTS $IPO #IPO https://zpr.io/Ln98GBeWtayG
0 · Reply
StockChasingBags
StockChasingBags Dec. 12 at 7:35 PM
$AKTS
1 · Reply
LeiteCondensado
LeiteCondensado Dec. 5 at 8:18 PM
$AKTS - A year since we became bagholders for life. Happy Birthday y’all..🥳🎉🎂
1 · Reply
kingofspin
kingofspin Nov. 25 at 1:00 AM
$AKTS where is my money I can’t sell it?????
1 · Reply
krakensos
krakensos Nov. 15 at 10:11 AM
$AKTS Did anyone send an email? I haven't sent anything, I'm embarrassed, haha.
1 · Reply
m2014
m2014 Nov. 12 at 10:06 PM
$AKTS
0 · Reply
hassle
hassle Nov. 8 at 9:53 AM
$AKTS Here is summary by ai, of the bankruptcy plan, basically a wipe out for shareholders. ------------------------------------- Bottom line: Unsecured noteholders and other Class 4A creditors are the only economic stakeholders with a recovery. Shareholders are wiped out. 📅 Key Milestones Event Date / Status Petition Date December 16 2024 Plan Filed October 30 2025 Voting Deadline December 3 2025 Combined Confirmation Hearing To be scheduled (post-December 3 2025) Effective Date After court confirmation order becomes final 🧮 Practical Impact Summary Stakeholder Outcome Secured / Priority Creditors Paid in full. Unsecured Noteholders (6.0% 2027) Receive pro rata share of available cash and residuals — likely small recovery (percentage TBD). Trade & Intercompany Creditors Either paid in full or neutralized. Equity Holders (Common Stock) Canceled; receive nothing. Executives / Board Removed on effective date. Plan Administrator Sole fiduciary managing liquidation and distributions.
0 · Reply
A98878
A98878 Nov. 7 at 11:52 AM
$AKTS Akoustis (now ATech) is still under the Chapter 11 process in court. The final plan has not been fully decided yet, and future actions — like mergers or possible distributions — may happen later. To make sure you don’t lose your rights, every shareholder should: 1. Send a short letter or email to the court (Case No. 24-12796-LSS) saying you want to keep your rights as a shareholder. 2. Write that your notice is made “without prejudice,” which means you want to stay included in any future value or decision. 3. Keep proof that you own shares and a copy of what you send. Even if there is no payout now, future value might appear later. Don’t lose your chance by staying silent. Please act soon and share this message with other shareholders. Together we can make sure our ownership and rights are not ignored. Best regards,
1 · Reply
m2014
m2014 Nov. 6 at 6:02 PM
$AKTS hello what is your price targets?
1 · Reply
krakensos
krakensos Nov. 5 at 8:59 PM
$AKTS I saw the latest documents on Stretto and they've already uploaded a proposal to liquidate the company. I didn't read everything; I just posted it on Gemini, and yes, the shares are going to be liquidated. I saw on my broker, IBKR, that there's a sale of 10,000 shares for 0.0009. Basically, what we saw with the price increases was people wanting to get rid of their shares, and nobody was buying them, so they went down to zero, haha.
1 · Reply
krakensos
krakensos Nov. 5 at 8:47 PM
$AKTS 0.0009 800% increase why my portafolio doesnt look like that up
0 · Reply
krakensos
krakensos Oct. 31 at 8:38 PM
$AKTS again going up its funny
0 · Reply